Medication/ja: Difference between revisions

@@ Line 57: / Line 57: @@
 == 分類 ==
-<div lang="en" dir="ltr" class="mw-content-ltr">
+{{main/ja|Durg class/ja}}
-{{main|Drug class}}
+重要な分類の一つは、従来の[[small molecule/ja|低分子]]医薬品（通常、化学合成から得られる）と[[biologic medical product/ja|生物学的製剤]]（[[recombinant proteins/ja|組み換えタンパク質]]、[[vaccines/ja|ワクチン]]、治療的に用いられる[[blood products/ja|血液製剤]]（[[IVIG/ja|IVIG]]など）、[[gene therappy/ja|遺伝子治療]]、[[cell therapy/ja|細胞治療]]（例えば、[[stem cell/ja|幹細胞]]治療）を含む）との間の分類である。
-One of the key classifications is between traditional [[small molecule|small molecule]] drugs; usually derived from chemical synthesis, and [[biologic medical product|biologic medical product]]s; which include [[recombinant proteins|recombinant proteins]], [[vaccines|vaccines]], [[blood products|blood products]] used therapeutically (such as [[IVIG|IVIG]]), [[gene therapy|gene therapy]], and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies).
-</div>
 <div lang="en" dir="ltr" class="mw-content-ltr">